AUR-1545, identified by its CAS number 3031593-79-7, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications, particularly in the field of oncology. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category often exhibit properties that enable them to interact with biological targets, potentially inhibiting tumor growth or modulating cellular pathways. AUR-1545 may demonstrate selectivity for certain receptors or enzymes, contributing to its efficacy in cancer treatment. Additionally, like many experimental compounds, it may undergo extensive pharmacological testing to assess its safety, bioavailability, and pharmacokinetics. As research progresses, further details regarding its mechanism of action, side effects, and clinical applications may emerge, providing a clearer understanding of its role in therapeutic regimens. Always consult scientific literature or databases for the most current and detailed information regarding specific compounds.

AUR-1545

3031593-79-7: AUR-1545, identified by its CAS number 3031593-79-7, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications, particularly in the field of oncology. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category often exhibit properties that enable them to interact with biological targets, potentially inhibiting tumor growth or modulating cellular pathways. AUR-1545 may demonstrate selectivity for certain receptors or enzymes, contributing to its efficacy in cancer treatment. Additionally, like many experimental compounds, it may undergo extensive pharmacological testing to assess its safety, bioavailability, and pharmacokinetics. As research progresses, further details regarding its mechanism of action, side effects, and clinical applications may emerge, providing a clearer understanding of its role in therapeutic regimens. Always consult scientific literature or databases for the most current and detailed information regarding specific compounds.

<p>AUR1545 is a selective KAT2A/KAT2B degradator exhibiting inhibitory activity against cancer models including AML, SCLC, and NEPC, and suppressing tumour growth in the NCI-H1048 xenograft model.</p>

CAS 3031593-79-7

AUR-1545

AUR1545

Ref: TM-T205224